Asset

Lidocaine

DENTSPLY SIRONA Inc. Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (1)

NCT IDPhaseStatusStartCompletionSponsor nameTitle
NCT01591616phase4completed2010-04-012012-04-01Dentsply InternationalPediatric Study to Access Pharmacokinetics and Safety of Oraqix Gel

FDA applications (1)

ApplicationTypeApplicant
NDA 021451NDADENTSPLY PHARMACEUTICAL INC

Marketed products (1)

  • ORAQIX